TY - JOUR
T1 - Let’s do better
T2 - public representations of COVID-19 science
AU - Caulfield, Timothy
AU - Bubela, Tania
AU - Kimmelman, Jonathan
AU - Ravitsky, Vardit
N1 - Publisher Copyright:
Copyright: © 2021 Caulfield et al.
PY - 2021/3/25
Y1 - 2021/3/25
N2 - COVID science is being both done and circulated at a furious pace. While it is inspiring to see the research community responding so vigorously to the pandemic crisis, all this activity has also created a churning sea of bad data, conflicting results, and exaggerated headlines. With representations of science becoming increasingly polarized, twisted, and hyped, there is growing concern that the relevant science is being represented to the public in a manner that may cause confusion, inappropriate expectations, and the erosion of public trust. Here we explore some of the key issues associated with the representations of science in the context of the COVID-19 pandemic. Many of these issues are not new. But the COVID-19 pandemic has placed a spotlight on the biomedical research process and amplified the adverse ramifications of poor public communication. We need to do better. As such, we conclude with 10 recommendations aimed at key actors involved in the communication of COVID-19 science, including government, funders, universities, publishers, media, and the research communities.
AB - COVID science is being both done and circulated at a furious pace. While it is inspiring to see the research community responding so vigorously to the pandemic crisis, all this activity has also created a churning sea of bad data, conflicting results, and exaggerated headlines. With representations of science becoming increasingly polarized, twisted, and hyped, there is growing concern that the relevant science is being represented to the public in a manner that may cause confusion, inappropriate expectations, and the erosion of public trust. Here we explore some of the key issues associated with the representations of science in the context of the COVID-19 pandemic. Many of these issues are not new. But the COVID-19 pandemic has placed a spotlight on the biomedical research process and amplified the adverse ramifications of poor public communication. We need to do better. As such, we conclude with 10 recommendations aimed at key actors involved in the communication of COVID-19 science, including government, funders, universities, publishers, media, and the research communities.
KW - Ethics
KW - Health policy
KW - News media
KW - Public health
KW - Science communication
KW - Science policy
KW - Scientific integrity
UR - http://www.scopus.com/inward/record.url?scp=85105321423&partnerID=8YFLogxK
U2 - 10.1139/facets-2021-0018
DO - 10.1139/facets-2021-0018
M3 - Article
AN - SCOPUS:85105321423
SN - 2371-1671
VL - 6
SP - 403
EP - 423
JO - Facets
JF - Facets
IS - 1
ER -